Warten auf den Duke Report

Hört sich vielversprechend an. Vllt brings der September

As the CEO of Wellstar, I wanted to take the time to provide a current update of events at the company.

We have been working very hard to have our Trillennium Medical Imaging (TMI) System ready to go to market. We are anxiously awaiting the Duke Study on our TMI System to be published in the ADVANCES IN SKIN AND WOUND CARE PUBLICATION JOURNAL. We have answered several rounds of questions and are confident that we will have the results published in August or September. This will obviously be a very important milestone for Wellstar International as this independent report will validate the results we have been seeing and reinforce the demand for our Trillennium Medical Imaging System in the marketplace.

The timing of the publication coincides with our new camera being completed and ready for mass production. As previously announced, we have contracted with a multibillion dollar manufacturer to have the camera designed to be market ready and user friendly. Up until this point, we have been in Beta Tests and getting good results with our current camera. This testing period has given us the ability to learn how to improve the system in our target work environment and we have done so. We have been able to design a better camera specifically made for our market which includes Hospitals, Nursing Homes and Long Term Care Facilities (LTAC). We also have been able to reduce the cost of the system by more than 40%. When the company starts to place systems with the price savings our path to profitability will be very quick. The company expects to be cash flow positive within 3 months of our initial launch.

The company will continue to market its new system to hospitals, nursing homes and long term care facilities for installations starting in November. In the interim, we will continue ongoing trials and additional beta testing in facilities with our existing system.

To recap, Wellstar is well positioned to be the first to market with a system that can predict deep tissue injury that leads to pressure ulcers or bed sores. Wellstar will start full scale marketing in November of 2010 upon the publication of the results of the Duke Study and the new TMI Camera being ready for mass production. This is a very exciting time for Wellstar and its shareholders. We have worked very hard to get to this point and have remained steadfast to our goal to be first to market with a superior product and we are nearing that point. Your constant support is greatly appreciated and we look to a very successful 2nd half of 2010.

Regards:

John Antonio
Chief Executive Officer
Wellstar International, Inc.  

Ist sie nicht schön ????

Die sollten lieber mal gute Neuigkeiten auf ihre neue Webseite schreiben.


Wellstar Announces New Website
Wellstar International Inc. (BB) (OTCBB:WLSI)
Today : Monday 27 September 2010
Wellstar (OTCBB: WLSI) through its wholly owned subsidiary Trillennium Medical Imaging (TMI) announces that they have implemented a new website.

The new website can be viewed at www.wellstar.us.

John Antonio, CEO of TMI states: “With our new Imaging system getting closer to roll out, the company will be making a full scale marketing effort to the medical community. While educating the marketplace on how our system can be utilized to increase revenues and prevent pressure ulcers from breaking the skin, the company needed to update it’s website to be more informational and user friendly. Included in the website are two videos. One video is a demonstration of the system and the other video is an interview with me. This is the company’s first step to go to market.”

......

http://ih.advfn.com/...mona&article=44535133&symbol=NB%5EWLSI

Wellstar International, Inc. Announces the Results for Publication of the Duke University Study Have Been Accepted

Wellstar International Inc. (OTCBB:WLSI) announces that the publication of “Advances of Skin and Wound Care” medical journal has approved the manuscript submitted and will be publishing the results of the Duke Study.

The company has just been informed that, after several months of review and two rounds of questions and answers, the leading publication in wound care has informed the authors of the manuscript written based on the results of the completed Duke Study, that after careful review they feel it will make a valuable contribution to Advances in Skin and Wound Care Journal to publish the findings of the Duke Study.

John Antonio, CEO of Wellstar and TMI states, “This is a monumental time for us. We have been working very hard to deliver a finished product that would be acceptable to the medical market, with emphasis on the hospital and long term care industry. While we have had excellent White Papers to share during our presentations, we now have the leading medical journal on wounds publishing our results. This will open up the market to us and we can start to pursue discussing firm placements with the prospective clients which include every hospital in the United States. Our next major step is the completion of our new camera which should be completed and tested by the end of November 2010. This will allow us to start our roll out of our systems in the first quarter of 2011.”

When the company receives the firm date of the publication, it will be announced.

http://ih.advfn.com/...mona&article=44572285&symbol=NB%5EWLSI

Aceacebaby Member Profile   Aceacebaby       Share     Sunday, October 10, 2010 12:09:15 PM
Re: slojab post# 6516 Post # of 6529
MESSAGE FROM ADVANCES IN SKIN AND WOUND CARE

Hello Amy,

Thank you for your inquiry. As I'm sure you know, we plan our issues far in advance. We've already begun working on 2011 issues. Because the article was just accepted, I do not have a targeted date as yet but I am going to try to get it published within the first half of 2011. Once we begin the editing process, we'll be in contact with the lead author. I understand there is interest re: the study so I'll keep that in mind as I consider my upcoming content.

Best regards,

Kathleen A. Greaves
Senior Managing Editor

Advances in Skin & Wound Care

Wolters Kluwer Health Medical Research

Lippincott, Williams & Wilkins

323 Norristown Road, Suite 200

Ambler, PA 19002



215-628-7772 tel

215-367-2147 fax

Kathleen.Greaves@wolterskluwer.com  

Ist zwar nur sinngemäß aber besser wie nix

hallo Amy

Danke für ihre Anfrage.Wie Sie sicher wissen planen wir unsere Beiträge weit im voraus.Wir sind momentan in den Planungen für unsere Beiträge in 2o11.Da der Artikel gerade erst akzeptiert wurde , habe ich noch kein festen Zeitpunkt für die Veröffentlichung,aber ich versuche ihn im ersten Quartal 2o11 zu veröffentlichen.Sobald wir mit dem Überarbeiten des Artikels beginnen (also in ein lesbares format bringen )werden wir Kontakt mit dem Autor aufnehmen .Ich verstehe das Interesse an der Veröffentlichung des Artikels/Studie.Aus diesem Grund werde ich dies im Hinterkopf behalten wenn es um die Nächsten Themen geht.


ist wie gesagt nicht haargenau übersetzt also ...

greets Schnöf  

von dem User Mhas1 der wohl ebenfalls per email in Kontakt mit der Advances in Skin and Wound care  steht.

http://messages.finance.yahoo.com/...f=3&rt=2&frt=2&off=1

The journal editors told me that the Duke study is currently scheduled for publication in the summer of 2011. I don't know which month, but hopefully May or June. Duke Univ. may be able to negociate with the journal to have it published sooner (of course this must be requested and funded by wellstar). I have no idea if such a request has been placed.

As for the market penetration, you should understand that medical thermal immaging is not a new technology, it has been in use since 1982 soon after the technology was approved by FDA. However, wellstar has found a new application for the technology, that is the diagnosis of pressure ulcers. The technology has been used for many other application such as the early breast cancer detection, differential diagnosis of pain dysfunctions, (such as Reflex Sympathetic Dystrophy, Neuromuscular Skeletal Syndromes and Neurological disorders),as well as orthopedic applications and lately the wellstar developed application for the early detection of pressure ulcers and deep tissue injuries.

Other than early detection of pressure ulcers and deep tissue injuries, the market is saturated with devices from multi-billion-dollar companies.

The pressure ulcer application is unique to wellstar and it is a huge market if you consider the worldwide need for it. Over the years wellstar can be a muli-billion-dollar company.

With regard to the existing applications, wellstar must provide services at a deep discout from their competitors.

The most difficult time for wellstar is the next 6 months, if they could get their product to roll out, the rest is easy, so I would say give it 6-12 months, it is one of the few penny stocks that have a good potential. The Duke study is the assurance for their technology.

Our biggest risk at this time is if Antonio makes an idiotic decision to excercise a R/S, this will dash the hopes of all shareholders.

glta  

Der zuständige Redakteur/Herausgeber des Journals ,erklärte mir das die Duke Studie bereits mit einem Termin zur Veröffentlichung im Sommer 2o11 vorgesehen ist.Der Monat genau ist nicht klar er hofft jedoch im Mai oder Juni.Die Duke Universität könnte evtl mit dem Journal eine Übereinkunft treffen ,dass der Artikel eher veröffentlicht wird.(das muss natürlich von Wellstar gewollt und bezahlt werden).er hat jedoch keine Ahnung obe eine solche Anfrage seitens Wellstar statt gefunden hat.

Dann geht es weiter mit einer Einschätzung des Users über das Marktumfeld und die Chancen von Wellstar.

Für den zu erwartenden Marktanteil bzw Chancen auf diesem , muss man wissen das Thermal Imaging keine neue Technologie ist.Es gibt sie bereits seit 1982 auf dem Markt ,nach dem diese eine FDA Zulassung erhielt.Wellstar hat lediglich eine neue Möglichkeit entwickelt diese Technologie zu nutzen um zb Druckgeschwüre früh zu erkennen.Die Technologie selbst ist zb in der Brustkrebserkennung [.... ]oder in der Orthopädie im Einsatz.[...]

Anders als in der Früherkennung von Druckgeschwüren oder Tiefgewebe Verletzungen,besteht ein Sättigung mit Geräten von Großunternehmen.

Das System von Wellstar zur Druckgeschwür Erkennung ist momentan einzigartig,wenn man sich nun die Einsatzmöglichkeiten  und deren Bedarf vorstellt, könnte man davon ausgehen das Wellstar die Möglichkeiten habe um kräftig zu wachsen.

[..]

Die nächsten 6-12 Monate könnten für Wellstar entscheidend sein.Wenn Wellstar es schafft das Produkt auf den Markt zu bringen kommt der Rest von allein.
Es ist einer dieser Pennystocks der ein gutes Potential hat.Die Duke Studie ist eine Rückversicherung für diese Technologie.

Das größte Risiko besteht darin das Antonio (CEO Wellstar) irgend eine idiotische Entscheidung trifft zb noch nen R/S.Dies würde das letzte vertrauen der Anleger zerstören.

So ist nicht wörtlich übersetzt und gekürzt , aber besser wie diese mist google Übersetzungeng. - Schnöf  

ich denke nicht, dass die etwas bezahlen können, um das erscheinungsdatum des artikels nach vorne zu verlegen.
allerdings wäre es für wellstar von vorteil - je eher könnte die vermarktung beginnen

bei 1,6mrd oder waren es schon 15 mrd aktien (?) erscheint ein r/s allerdings wahrscheinlich.

- Notification that Annual Report will be submitted late (NT 10-K)

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 12b-25

Commission File Number   333-130295

NOTIFICATION OF LATE FILING
 
T  Form 10-K     ¨ Form 11-K     ¨ Form 20-F     ¨ Form 10-Q     ¨ Form N-SAR


For Period Ended: July 31, 2010
 
¨ Transition Report on Form 10-K
¨ Transition Report on Form 20-F
¨ Transition Report on Form 10-Q
¨ Transition Report on Form N-SAR


For the Transition Period Ended: _________


Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.


If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
 
 

--------------------------------------------------

 


PART I
REGISTRANT INFORMATION
 
Full name of registrant     Wellstar International, Inc.  
Former name if applicable        
Address of principal executive office     6911 Pilliod Road  
City, state and zip code     Holland, Ohio, 43528  





PART II
RULE 12b-25 (b) AND (c)


If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25 (b), the following should be completed. (Check box if appropriate.)


T  (a)  The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;  
     
(b)  The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K or  Form N-SAR or Form N-CSR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and  
     
  (c)  The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.  



 
 
--------------------------------------------------

 
 
PART III
NARRATIVE


State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed within the prescribed time period.


The Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2010 cannot be filed within the prescribed time period because the Company requires additional time for compilation and review to insure adequate disclosure of certain information required to be included in the Form 10-K.  The Company’s Annual Report on Form 10-K will be filed on or before the 15 th calendar day following the prescribed due date.
 


PART IV
OTHER INFORMATION


(1)  Name and telephone number of person to contact in regard to this notification  

 
John Antonio, CEO     (419)     865-0069  
(Name)     (Area Code)     (Telephone Number)  



(2)  Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If the answer is no, identify report(s).  

T Yes     ¨ No

(3)  Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?  

¨ Yes     T   No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
--------------------------------------------------

Wellstar International, Inc.
Name of Registrant as Specified in Charter.

Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
         
           
Date: October 29, 2010  By:  /s/ John Antonio    
     John Antonio    
     Chief Executive Officer    
           

 

http://ih.advfn.com/p.php?pid=nmona&article=45016882

http://ih.advfn.com/p.php?pid=nmona&article=45246937

lasst mich meiner Worte Lügen strafen, aber wenn ich Passagen wie diese lese
Plan of Operation and Financing Needs  

We are seeking financing in different amounts and up to 12 million dollars.  Currently the company has exhausted its funding from it’s past agreements with JMJ Financial and is actively trying to secure financing to continue operations. If the company is successful in securing financing the company will continue to develop its camera and complete the Beta Test that is currently in operation in a Long Term Care Facility.
We presently do not have any available credit, bank financing or other external sources of liquidity. Due to our brief history and historical operating losses, our operations have not been a source of liquidity. We will need to obtain additional capital in order to expand operations and become profitable.  In order to obtain capital, we may need to sell additional shares of our common stock or borrow funds from private lenders. There can be no assurance that we will be successful in obtaining additional funding.

We will still need additional capital in order to continue operations until we are able to achieve positive operating cash flow. Additional capital is being sought, but we cannot guarantee that we will be able to obtain such investments. This money would be used for the roll out of our TMI System to the long term care market and for the development and production of a new camera that will save the company money as well as be more effective in its diagnosis..

dann  habe ich arge Bedenken dass diese Firma noch den nächsten Frühling erlebt ...  

und was diese super Kamera betrifft , die ist somit wohl immernoch nicht Serienreif.
und wenn die eh schon keine Kohle haben dann auch nicht um die Publikation der Studie zu beschleunigen....Duke Univ. may be able to negociate with the journal to have it published sooner (of course this must be requested and funded by wellstar)....

irgendwie nen scheiss herbst was
wamu,ambac,wellstar.... more to come ^^  

- Quarterly Report (10-Q)
Date : 12/15/2010 @ 5:16PM
Source : Edgar (US Regulatory)
Stock : (WLSI)
Quote :  0.0001  0.0 (0.00%) @ 7:27AM


http://ih.advfn.com/p.php?pid=nmona&article=45673092

Wellstar International, Inc. - FORM 8-K - April 6, 2011


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934


Date of Report (Date of earliest reported): April 6, 2011


WELLSTAR INTERNATIONAL, INC.
(Exact name of registrant as specified in charter)


Nevada 333-130295 20-1834908
(State  or  Other  Jurisdiction of Incorporation
or Organization) (Commission File Number) (IRS Employer Identification No.)


6911 Pilliod Road
Holland, Ohio 43528
(Address of principal executive offices) (Zip Code)


Registrant's telephone number, including area code: (419) 865-0069


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 8.01 Other Events


On April 6, 2011, Wellstar International, Inc. (the “Company”) announced that it has ceased operations.  The Company phone number has been disconnected and the lease for the Holland, Ohio facility has been terminated.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  WELLSTAR INTERNATIONAL, INC.    
           
Date: April 6, 2011 By: /s/ John Antonio    
     Name: John Antonio    
     Title: CEO    
           

lass zum kollektiven anteilschein verbrennen treffen ^^  

...im Haus von John Antonio.

Der verkauft das Ding garantiert unter der Hand....

Hab es jetzt erst bemerkt.

Geile Übung. Naja, im Depot liegen sie noch.

Vielleicht hat ja jemand Interesse ?

Loool